SARS-CoV-2 Virus-like Particles Produced by a Single Recombinant Baculovirus Generate Anti-S Antibody and Protect against Variant ChallengeArticle Published on 2022-04-272023-07-01 Journal: Viruses [Category] COVID19(2023년), SARS, [키워드] antigenicity baculovirus coronavirus COVID-19 immunogenicity neutralizing antibody protection recombinant SARS VLP [DOI] 10.3390/v14050914 PMC 바로가기 [Article Type] Article
Cerebrovascular Complications of COVID-19 and COVID-19 VaccinationReview Published on 2022-04-152023-07-08 Journal: Circulation research [Category] COVID19(2023년), [키워드] 19 2 CoV COVID Pandemics SARS stroke Vaccines [DOI] 10.1161/CIRCRESAHA.122.319954 PMC 바로가기 [Article Type] Review
A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation: study protocol (ICAT-COVID)SARS-CoV-2(COVID-19)에 감염되어 침습적 기계 환기 없이 병원에 입원한 환자에서 이카티반트의 효능과 안전성을 평가하기 위한 다기관, 공개 라벨, 무작위, 개념 증명 II상 임상 시험: 연구 프로토콜(ICAT-COVID)Article Published on 2022-04-122022-09-11 Journal: Trials [Category] COVID19(2023년), SARS, 임상, [키워드] 1:1 ACE2 acute respiratory distress acute respiratory distress syndrome Antigen ARDS attacks bradykinin caused Clinical efficacy clinical status clinical trial ClinicalTrials Comorbidity control group COVID-19 COVID-19 patient COVID-19 patients COVID-19 pneumonia Cytokine storm death Diagnosis discharge discharged doses effective Effectiveness Efficacy Efficacy and safety eligible Endothelial cell endothelial cells EudraCT Evidence evidence of expected experimental group global pandemic Healthcare system Healthcare systems hospital Hospitalized Icatibant include infected with SARS-CoV-2 Inflammatory response inhibiting invasive mechanical Invasive mechanical ventilation Mortality multicenter Open-label outcome Patient patients hospitalized Pneumonia Primary outcomes protease pulmonary infiltrates Radiographic randomization Randomized receive receptor receptor antagonist respiratory distress Respiratory distress syndrome RT-PCR Safe Sample size SARS SARS-CoV-2 secondary Secondary outcomes Spain Standard of care Study protocol subcutaneously Symptoms syndrome the SARS-CoV-2 the WHO thought treat Treatment viral infection with COVID-19 working hypothesis [DOI] 10.1186/s13063-022-06219-7 PMC 바로가기 [Article Type] Article
Effects of Treatment of Coronavirus Disease 2019 With Convalescent Plasma in 25 B-Cell-Depleted Patients25명의 B-세포 결핍 환자에서 회복기 혈장으로 코로나바이러스 질병 2019 치료의 효과Article Published on 2022-04-092022-09-12 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), SARS, 진단, [키워드] 19 2 antibody B B-cell-depleted patient Cell cell depletion convalescent convalescent plasma coronavirus disease CoV COVID diagnosed Effect immunodeficiency median neutralizing antibody titers remained SARS symptomatic therapeutic effect therapy treated [DOI] 10.1093/cid/ciab647 PMC 바로가기 [Article Type] Article
TB and COVID-19: An Exploration of the Characteristics and Resulting Complications of Co-infectionArticle Published on 2022-04-042023-06-15 Journal: Frontiers in bioscience (Scholar edition) [Category] MERS, SARS, [키워드] active TB anti-inflammatory agents bronchiectasis cavitation Co-infection COVID-19 Epidemiology fibrosis IFN IL-10 IL-35 immune response latent TB MERS regulatory T cells SARS TB treatment TGF-β TNF-α Tuberculosis [DOI] 10.31083/j.fbs1401006 PMC 바로가기 [Article Type] Article
Detection and identification of coronaviruses in human tissues using electron microscopyReview Published on 2022-04-042023-06-15 Journal: Microscopy research and technique [Category] COVID19(2023년), MERS, SARS, [키워드] coronavirus COVID‐19 electron microscopy SARS SARS‐CoV‐2 ultrastructure [DOI] 10.1002/jemt.24115 PMC 바로가기 [Article Type] Review
SARS-CoV-2 IgG Seroprevalence among Blood Donors as a Monitor of the COVID-19 Epidemic, Brazil브라질 COVID-19 전염병의 모니터로서 헌혈자 사이의 SARS-CoV-2 IgG 혈청 유병률Article Published on 2022-04-012022-09-12 Journal: Emerging Infectious Diseases [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] acute respiratory syndrome Blood blood donor Blood donors Brazil collected compartmental model compose coronavirus coronavirus disease COVID-19 cumulative disease Diseases Epidemic epidemic model Epidemics estimate hidden IgG incidence incidence rate information Modification reported respiratory infections SARS SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 transmission rate serology Seroprevalence serum sample severe acute respiratory syndrome coronavirus 2 Surveillance the epidemic variables viruses zoonoses [DOI] 10.3201/eid2804.211961 PMC 바로가기 [Article Type] Article
Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed Individuals코로나바이러스 질병 2019 메신저 RNA 백신 면역억제된 개인의 면역원성Article Published on 2022-04-012022-09-11 Journal: The Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] 19 vaccine 2 acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition antibody Antibody Response Antibody responses binding CD4 CD8 T-cell coronavirus coronavirus disease Coronavirus disease 2019 CoV COVID COVID-19 COVID-19 mRNA Vaccination cross-reactivity function Immunocompromised immunocompromised individuals immunogenicity immunosuppressive increased mortality individual individuals Infection interferon interferon-γ lead messenger Messenger RNA mRNA mRNA vaccination mRNA vaccine Neutralizing reduce reduced regimen respiratory response RNA SARS SARS-CoV-2 SARS-CoV-2 variants severe acute respiratory syndrome Coronavirus T cells therapy These data vaccine immunogenicity Viral viral clearance Viral variants [DOI] 10.1093/infdis/jiab569 PMC 바로가기 [Article Type] Article
Prediction of putative potential siRNAs for inhibiting SARS-CoV-2 strains, including variants of concern and interest관심 및 관심의 변이체를 포함하여 SARS-CoV-2 균주를 억제하기 위한 잠정적 잠재적 siRNA의 예측Article Published on 2022-04-012022-09-11 Journal: Future Microbiology [Category] COVID19(2023년), SARS, 변종, [키워드] binding Characteristics coding sequence coronavirus strain COVID-19 expected in vitro in vivo inhibit inhibiting Measures Metadata Novel coronavirus predict predicted prediction RdRP Region sampling SARS SARS-CoV-2 SARS-CoV-2 protein SARS-CoV-2 proteins SARS-CoV-2 strains siRNA siRNAs therapeutic therapeutic intervention Transcription variants variants of concern variants of SARS-CoV-2 viral replication were used [DOI] 10.2217/fmb-2021-0130 PMC 바로가기 [Article Type] Article
Contamination: The Case of Civets, Companionship, COVID, and SARSArticle Published on 2022-04-012023-06-22 Journal: Journal of applied animal welfare science : JAAWS [Category] 조류인플루엔자, [키워드] animal welfare COVID-19 palm civet SARS zoonoses [DOI] 10.1080/10888705.2022.2028627